Stay updated on Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and criteria for a Phase 2 clinical trial on copper Cu 64 PSMA I&T injection for metastatic prostate cancer, while a new version number has been added.SummaryDifference20%
- Check67 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 24, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.8%
- Check110 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.